| Walker_1935_Proc.Roy.Soc.Med_28_759 | Case showing effect of prostigmin on myasthenia gravis |
| Dale_1935_Proc.R.Soc.Med_28_319 | Pharmacology and Nerve-endings (Walter Ernest Dixon Memorial Lecture): (Section of Therapeutics and Pharmacology) |
| Dale_1935_Science_82_99 | The new ergot alkaloid |
| Dudley_1935_Br.Med.J_1_520 | The substance for the traditional clinical effect of ergot |
| Dudley_1935_Science_81_559 | The new active principle of ergot |
| Kirsh_1935_Int.J.Plant.Sci_97_321 | Lipase Production by Penicillium Oxalicum and Aspergillus flavus |
| Bacq_1935_Arch.Int.Physiol_42_24 | Recherches sur la physiologie et la pharmacologie du systeme nerveux autonome |
| Julian_1935_J.Am.Chem.Soc_57_755 | Studies in indole series. V. Complete synthesis of physostigmine (eserine) |
| Keith_1935_Arch.Neurol.Psychiatry_34_1022 | Experimental convulsions induced by administration of thujone |
| Lange_1935_Chem.Ztg_59_393 | Fortschritte auf dem Gebiete der Darstellung und Verwendung von Fluorverbiridungen |
| Rossi_1935_Arch.Ophthalmol_42_341 | Azzione sull'occhio di un nuovo farmaco sintetico exerino-simile: la prostigmina (Ricerche sperimetali e cliniche) |
| Stedman_1935_Biochem.J_29_2107 | The relative cholinesterase activities of serum and corpuscles from the blood of certain species |